Literature DB >> 15163499

Genetic relationships, serological cross-reaction and cross-protection between H1N2 and other influenza A virus subtypes endemic in European pigs.

Kristien Van Reeth1, Ian Brown, Steve Essen, Maurice Pensaert.   

Abstract

This study examines the genetic relationships between the recently emerged H1N2 swine influenza virus and viruses of H1N1 and H3N2 subtypes, and the extent of protection against H1N2 challenge in pigs immune after infection or vaccination with the other subtypes. There was low amino acid homology (70.4-71.9%) in the haemagglutinin (HA) gene between H1N1 viruses used for primary infection or vaccination and the H1N2 challenge strain, with 94-99 amino acid changes between these viruses involving all five antigenic sites. The NA genes of H3N2 viruses used for primary infection or vaccination showed higher amino acid homology with H1N2 (88.3-92.6%), while nucleoprotein (95.5-96.3% nucleotide identity) and matrix (96.8-98.4%) genes were most conserved between the three subtypes. Pigs immune as a result of intranasal inoculation with either H1N1 or H3N2 showed partial clinical protection against H1N2 challenge, and nasal virus excretion was 2 days shorter than in naive pigs. Moreover, dually infected (H1N1 + H3N2)-immune pigs showed complete clinical protection and H1N2 virus replication in the lungs and nasal secretions was either undetectable or markedly reduced. In contrast, a double vaccination with a commercial H1N1 and H3N2-based vaccine did not protect against H1N2 challenge. Haemagglutination inhibition (HI) or virus neutralisation (VN) tests of swine sera revealed little if any antigenic cross-reactivity between subtypes. These data suggest that serum HI or VN antibodies are not essential in heterosubtypic protection, but that mucosal or cellular immunity are probably involved. It is still unknown whether this type of cross-subtype protection will also occur in infection-immune pigs in the field.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163499     DOI: 10.1016/j.virusres.2004.02.023

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  29 in total

1.  Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Authors:  Jürgen A Richt; Porntippa Lekcharoensuk; Kelly M Lager; Amy L Vincent; Christina M Loiacono; Bruce H Janke; Wai-Hong Wu; Kyoung-Jin Yoon; Richard J Webby; Alicia Solórzano; Adolfo García-Sastre
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

2.  B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms.

Authors:  Javier Rangel-Moreno; Damian M Carragher; Ravi S Misra; Kim Kusser; Louise Hartson; Amy Moquin; Frances E Lund; Troy D Randall
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

3.  Inferring patterns of influenza transmission in swine from multiple streams of surveillance data.

Authors:  Christopher C Strelioff; Dhanasekaran Vijaykrishna; Steven Riley; Yi Guan; J S Malik Peiris; James O Lloyd-Smith
Journal:  Proc Biol Sci       Date:  2013-05-08       Impact factor: 5.349

4.  DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs.

Authors:  J Patrick Gorres; Kelly M Lager; Wing-Pui Kong; Michael Royals; John-Paul Todd; Amy L Vincent; Chih-Jen Wei; Crystal L Loving; Eraldo L Zanella; Bruce Janke; Marcus E Kehrli; Gary J Nabel; Srinivas S Rao
Journal:  Clin Vaccine Immunol       Date:  2011-09-14

5.  Intranasal vaccination with replication-defective adenovirus type 5 encoding influenza virus hemagglutinin elicits protective immunity to homologous challenge and partial protection to heterologous challenge in pigs.

Authors:  Douglas R Braucher; Jamie N Henningson; Crystal L Loving; Amy L Vincent; Eun Kim; Julia Steitz; Andrea A Gambotto; Marcus E Kehrli
Journal:  Clin Vaccine Immunol       Date:  2012-08-29

6.  Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.

Authors:  Ioanna Skountzou; Dimitrios G Koutsonanos; Jin Hyang Kim; Ryan Powers; Lakshmipriyadarshini Satyabhama; Feda Masseoud; William C Weldon; Maria Del Pilar Martin; Robert S Mittler; Richard Compans; Joshy Jacob
Journal:  J Immunol       Date:  2010-06-28       Impact factor: 5.422

7.  Reassortant between human-Like H3N2 and avian H5 subtype influenza A viruses in pigs: a potential public health risk.

Authors:  Yanlong Cong; Guangmei Wang; Zhenhong Guan; Shuang Chang; Quanpeng Zhang; Guilian Yang; Weili Wang; Qingfeng Meng; Weiming Ren; Chunfeng Wang; Zhuang Ding
Journal:  PLoS One       Date:  2010-09-07       Impact factor: 3.240

8.  Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs.

Authors:  Aleksandar Masic; Jayaum S Booth; George K Mutwiri; Lorne A Babiuk; Yan Zhou
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

9.  Age at Vaccination and Timing of Infection Do Not Alter Vaccine-Associated Enhanced Respiratory Disease in Influenza A Virus-Infected Pigs.

Authors:  Carine K Souza; Daniela S Rajão; Crystal L Loving; Phillip C Gauger; Daniel R Pérez; Amy L Vincent
Journal:  Clin Vaccine Immunol       Date:  2016-06-06

10.  Serologic and genetic characterization of North American H3N2 swine influenza A viruses.

Authors:  Marie René Gramer; Jee Hoon Lee; Young Ki Choi; Sagar M Goyal; Han Soo Joo
Journal:  Can J Vet Res       Date:  2007-07       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.